Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06440746
Status:
RECRUITING
Last Update Posted:
2024-06-04
First Post:
2024-05-28
Brief Title:
Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases
Sponsor:
R-Pharm International LLC
Organization:
R-Pharm
Organization Data
Organization:
R-Pharm
Class:
INDUSTRY
Study ID:
CL04041109
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
R-Pharm International LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Keystat LLC | UNKNOWN |
| R-Pharm | INDUSTRY |
| Exacte Labs LLC | UNKNOWN |
| Data Management 365 | INDUSTRY |